Details for New Drug Application (NDA): 021086
✉ Email this page to a colleague
The generic ingredient in ZYPREXA ZYDIS is olanzapine. There are thirty-three drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the olanzapine profile page.
Summary for 021086
Tradename: | ZYPREXA ZYDIS |
Applicant: | Cheplapharm |
Ingredient: | olanzapine |
Patents: | 0 |
Suppliers and Packaging for NDA: 021086
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086 | NDA | Eli Lilly and Company | 0002-4453 | 0002-4453-85 | 30 DOSE PACK in 1 CARTON (0002-4453-85) / 1 BLISTER PACK in 1 DOSE PACK (0002-4453-01) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086 | NDA | Eli Lilly and Company | 0002-4454 | 0002-4454-85 | 30 DOSE PACK in 1 CARTON (0002-4454-85) / 1 BLISTER PACK in 1 DOSE PACK (0002-4454-01) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 5MG | ||||
Approval Date: | Apr 6, 2000 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
Approval Date: | Apr 6, 2000 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 15MG | ||||
Approval Date: | Apr 6, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021086
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-004 | Apr 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-002 | Apr 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-002 | Apr 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-004 | Apr 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-002 | Apr 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-001 | Apr 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA ZYDIS | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086-003 | Apr 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription